Abstract

Efforts to take advantage of the beneficial activities of thyrotropin-releasing hormone (TRH) in the brain are hampered by its poor metabolic stability and lack of adequate central nervous system bioavailability. We report here novel and metabolically stable analogs that we derived from TRH by replacing its amino-terminal pyroglutamyl (pGlu) residue with pyridinium-containing moieties. Exploratory studies have shown that the resultant compounds were successfully delivered into the mouse brain after systemic administration via their bioprecursor prodrugs, where they manifested neuropharmacological responses characteristic of the endogenous parent peptide. On the other hand, the loss of potency compared to TRH in a model testing antidepressant-like effect with a simultaneous preservation of analeptic activity has been observed, when pGlu was replaced with trigonelloyl residue. This finding may indicate an opportunity for designing TRH analogs with potential selectivity towards cholinergic effects.

Highlights

  • Our laboratory has been involved in medicinal chemistry-driven research with attention to facilitating drug delivery of central nervous system (CNS) agents via prodrug approaches.Thyrotropin-releasing hormone (TRH), a small peptide, has been one of the main focuses in this regard [1,2,3,4,5]

  • In vitro stability studies in freshly made mouse brain homogenate and plasma [3,4,5,16], respectively, showed that 2 and 3 were metabolically stable; no significant degradations of the compounds were detected within 2 h by reversed-phase high-performance liquid chromatography (RP-HPLC)

  • We have confirmed that when the central histidyl residue (His) is replaced in the thyrotropin-releasing hormone (TRH) sequence with pyridinium-based amino acids, the resultant TRH analogs were metabolically stable [2,3]

Read more

Summary

Design and Exploratory Neuropharmacological Evaluation of

Katalin Prokai-Tatrai 1,2,*, Vien Nguyen 1, Szabolcs Szarka 1, Krisztina Konya 1,† and Laszlo Prokai 1.

Introduction
Animals
Synthesis of Test Compounds
In Vitro Metabolic Stability
Analeptic Effect
Data Analysis
Results and Discussion
Conclusions
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.